Comorbidities in SARS-CoV-2 Patients: a Systematic Review and Meta-Analysis

DOI Web Site 1 Citations
  • Wern Hann Ng
    Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
  • Thomas Tipih
    Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Nigel A. Makoah
    Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Jan-G Vermeulen
    Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Dominique Goedhals
    Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Joseph B. Sempa
    Department of Biostatistics, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Felicity J. Burt
    Division of Virology, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa
  • Adam Taylor
    Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
  • Suresh Mahalingam
    Emerging Viruses, Inflammation and Therapeutics Group, Menzies Health Institute Queensland, Griffith University, Gold Coast, Southport, QLD, Australia
  • Diane E. Griffin
    editor

Description

<jats:p>COVID-19 has plagued the world since it was first identified in December 2019. Previous systematic reviews and meta-analysis were limited by various factors such as the usage of non-peer reviewed data and were also limited by the lack of clinical data on a global scale.</jats:p>

Journal

  • mBio

    mBio 12 (1), e03647-, 2021-02-23

    American Society for Microbiology

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top